carteolol has been researched along with Arrhythmias, Cardiac in 3 studies
Carteolol: A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.
Arrhythmias, Cardiac: Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The results are summarized of 13 published investigations of the beta-blocker 5-(3-tert-butylamino-2-hydroxy-propoxy)-3, 4-dihydro-2(1H)-quinolinone hydrochloride (carteolol hydrochloride, Endak, Endak mite) with a total of 378 patients suffering from cardiac rhythm irregularities (tachycardias, extrasystoles (ES), arrhythmias)." | 7.66 | [Clinical results with carteolol in patients with arrhythmias]. ( Strösser, W, 1983) |
| "Oxprenolol and carteolol were observed to have mild effects on the abnormal ECG as compared with propranolol." | 5.27 | [The abnormal ECG and the appearance of methacholine-induced arrhythmias in SART mice and effects of beta-blockers, oxprenolol, propranolol, and carteolol]. ( Harada, N; Hata, T; Itoh, E; Kita, T, 1984) |
| "Penbutolol and carteolol are two new long acting, nonselective beta-adrenergic blockers which have been approved for the treatment of systemic hypertension." | 4.78 | Penbutolol and carteolol: two new beta-adrenergic blockers with partial agonism. ( Covey, S; Frishman, WH, 1990) |
| "The results are summarized of 13 published investigations of the beta-blocker 5-(3-tert-butylamino-2-hydroxy-propoxy)-3, 4-dihydro-2(1H)-quinolinone hydrochloride (carteolol hydrochloride, Endak, Endak mite) with a total of 378 patients suffering from cardiac rhythm irregularities (tachycardias, extrasystoles (ES), arrhythmias)." | 3.66 | [Clinical results with carteolol in patients with arrhythmias]. ( Strösser, W, 1983) |
| "Oxprenolol and carteolol were observed to have mild effects on the abnormal ECG as compared with propranolol." | 1.27 | [The abnormal ECG and the appearance of methacholine-induced arrhythmias in SART mice and effects of beta-blockers, oxprenolol, propranolol, and carteolol]. ( Harada, N; Hata, T; Itoh, E; Kita, T, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hata, T | 1 |
| Kita, T | 1 |
| Itoh, E | 1 |
| Harada, N | 1 |
| Strösser, W | 1 |
| Frishman, WH | 1 |
| Covey, S | 1 |
1 review available for carteolol and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Penbutolol and carteolol: two new beta-adrenergic blockers with partial agonism.
Topics: Arrhythmias, Cardiac; Carteolol; Chemical Phenomena; Chemistry; Coronary Disease; Humans; Hypertensi | 1990 |
2 other studies available for carteolol and Arrhythmias, Cardiac
| Article | Year |
|---|---|
[The abnormal ECG and the appearance of methacholine-induced arrhythmias in SART mice and effects of beta-blockers, oxprenolol, propranolol, and carteolol].
Topics: Animals; Arrhythmias, Cardiac; Autonomic Nervous System Diseases; Carteolol; Disease Models, Animal; | 1984 |
[Clinical results with carteolol in patients with arrhythmias].
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Carteolol; Heart Rate; Humans; Hyperthyroidism; Propanola | 1983 |